NORTH
CHICAGO, Ill., May 25, 2022
/PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the
Bernstein 38th Annual Strategic Decisions Conference on
Wednesday, June 1, 2022. Richard A. Gonzalez, chairman and chief
executive officer, will present at 10:00
a.m. Central Time.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
About AbbVie
AbbVie's mission is to discover and
deliver innovative medicines that solve serious health issues today
and address the medical challenges of tomorrow. We strive to have a
remarkable impact on people's lives across several key therapeutic
areas: immunology, oncology, neuroscience, eye care, virology,
women's health and gastroenterology, in addition to products and
services across its Allergan Aesthetics portfolio. For more
information about AbbVie, please visit us at www.abbvie.com. Follow
@abbvie on Twitter, Facebook, Instagram, YouTube and
LinkedIn.
View original
content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-bernstein-38th-annual-strategic-decisions-conference-301554489.html
SOURCE AbbVie